Norcross, GA (PRWEB) April 11, 2006
Auriga Pharmaceuticals, LLC, http://www.aurigalabs.com , a leading specialty pharmaceutical company, today announced that Alan Roberts, a long-time pharmaceutical industry executive, has been named senior vice president of scientific affairs.
Mr. Roberts brings 17 years of experience spanning the technical disciplines of the pharmaceutical industry, having built an impressive track record in regulatory affairs, research and development, manufacturing and the technical analysis of pharmaceutical product acquisitions. As a member of Auriga’s senior management team, he will be responsible for building out these same areas to support the company’s continued growth.
“Mr. Roberts brings important scientific and technical expertise to the Auriga management team,” said Philip Pesin, chairman and CEO of Auriga. “Alan is a great complement to the leadership team we have built during the last several months. He has a wealth of experience in the technical side of our business and has played a pivotal role in several smaller companies during their critical growth phases. We are very excited to have him on our management team.”
Most recently, Mr. Roberts served as vice president, global manufacturing and development, and vice president, scientific affairs for First Horizon Pharmaceutical Corporation. At First Horizon he established the regulatory, technical, and development environments for a company transitioning from non-application, ethical pharmaceuticals to FDA-approved, application products.
Prior to this, Mr. Roberts served as vice president, research and development, for Mikart, Inc., a private, pharmaceutical contract manufacturer, where he was instrumental in establishing the development program and achieving FDA application approvals. Mr. Roberts has also held key management positions in regulatory and development with Solvay Pharmaceuticals, Inc. and the Medical University of South Carolina’s Pharmaceutical Development Center, respectively.
Mr. Roberts holds a B.S. in Microbiology from Clemson University.
About Auriga Pharmaceuticals, LLC
Auriga Pharmaceuticals, LLC, a wholly-owned subsidiary of Auriga Laboratories, Inc., develops and markets new prescription products for approved drugs using proprietary drug delivery technologies and reformulation strategies. The specialty pharmaceutical company has a development division and a commercialization division, both based in Norcross, Georgia. A highly integrated team of experienced pharmaceutical executives manages product life cycle from development through marketing and sales. The company currently markets Extendryl®, a line of prescription cough/cold medications. More information is available at the company’s website at: http://www.aurigalabs.com
# # #